Cardiac amyloidosis — The great imitator June 01, 2015 Overview Show transcript Overview Mayo Clinic specialists explore the factors that should make cardiologists suspect cardiac amyloidosis. Martha Grogan, M.D., director, Mayo Clinic Cardiac Amyloid Clinic, Angela Dispenzieri, M.D., Hematology, and Nandan S. Anavekar, M.B., B.Ch., Cardiovascular Medicine, discuss the importance of raising awareness of the disease among cardiologists and reinforce the crucial steps to establishing a diagnosis and treatment plan. Share Doximity Facebook LinkedIn Twitter Print details Email Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleNew ATTR amyloidosis treatmentVideoGrand Rounds: Cardiac Amyloidosis: What Every Cardiologist Needs to KnowVideoTTR vs. AL cardiac amyloidosis: Don't rely on imaging alone VID-20433367 Medical Professionals Cardiac Amyloidosis — The Great Imitator